Closed to new investors.
NAV Price ()
Number of stocks
Risk Indicator

About this fund

Fund objectives

  • The Fund seeks to provide long-term capital growth.
  • The Fund employs an “active management” strategy to invest mainly in U.S. stocks, with an emphasis on companies that are considered to have prospects for rapid earnings growth. The Fund’s Sub-Investment Manager, PRIMECAP Management Company (“PRIMECAP”), uses fundamental research to identify stocks that are expected to outperform the market over a three to five-year time horizon and that are available at attractive prices relative to their fundamental values. The Fund has the flexibility to invest in companies of any size, but it mostly invests in small and mid-cap stocks.
  • The Fund may measure performance against the Russell 3000 Index (the “Index”), a market-capitalisation-weighted stock market index, composed of the top 3,000 US publically traded companies, as ranked by market capitalisation, or the total dollar value of all outstanding shares. The Fund is not otherwise constrained by or managed with reference to the Index. The Index does not define the investment universe of the Fund and the composition of the Fund may deviate significantly from that of the Index.
  • The Fund’s policy is to remain substantially invested in common stocks that are listed or traded on exchanges or markets in the United States.

Fund facts

Share class inception
19 Dec 2006
Minimum initial investment
£100,000.00
Investment structure
Irish UCITS
Share Class Assets'
Total Assets
Strategy
Active
Asset Class
Equity
Domicile
Ireland
Dividend schedule
Annually
Tax status
Austria, Germany, Switzerland and United Kingdom reporting
Currency
GBP
Legal entity
Vanguard Investment Series PLC
Investment manager

Vanguard Global Advisers, LLC
PRIMECAP Management Company

Benchmark
Russell 3000 Index

The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

Performance

Risk and Volatility

As at 30 Sep 2025

Beta
Annualized Tracking Error
1 year
3 years
5 years

Please note Beta and R-squared data will only display for funds with 3 full years of history.

The value of investments, and the income from them, may fall or rise and investors may get back less than they invested.

Portfolio data

Characteristics
FundamentalsFundBenchmarkAs at
Number of stocks 231 2,983 30 Sep 2025
Median market capital 19.1 B 179.1 B 30 Sep 2025
26.3 x 27.9 x 30 Sep 2025
3.8 x 4.6 x 30 Sep 2025
11.2% 23.8% 30 Sep 2025
16.7% 22.9% 30 Sep 2025
Portfolio turnover rate 16.6% 30 Sep 2025
Market allocation

As at 30 Sep 2025

CountryRegionFundBenchmarkVariance +/-
United States of AmericaNorth America 88.67% 99.28% -10.61%
ChinaEmerging Markets 6.04% 0.00% 6.04%
OtherOther 2.97% 0.41% 2.56%
CanadaNorth America 1.03% 0.00% 1.03%
GermanyEurope 0.50% 0.00% 0.50%
SwitzerlandEurope 0.37% 0.00% 0.37%
United KingdomEurope 0.20% 0.00% 0.20%
FranceEurope 0.15% 0.00% 0.15%
IsraelMiddle East 0.07% 0.00% 0.07%
ArgentinaEmerging Markets 0.00% 0.00% 0.00%
PanamaEmerging Markets 0.00% 0.00% 0.00%
BrazilEmerging Markets 0.00% 0.11% -0.11%
PeruEmerging Markets 0.00% 0.02% -0.02%
SingaporePacific 0.00% 0.00% 0.00%
Hong KongPacific 0.00% 0.00% 0.00%
Holdings details

As at 30 Jun 2025

Holding name% of market valueSectorRegionMarket valueShares
Eli Lilly & Co 4.22388% Health Care US £51,069,348.89 65,513
Flex Ltd 3.22631% Information Technology US £39,008,037.12 781,411
Micron Technology Inc 2.73624% Information Technology US £33,082,765.00 268,420
NEXTracker Inc 2.12288% Industrials US £25,666,935.23 472,079
Xometry Inc 2.08207% Industrials US £25,173,550.00 745,000
Alphabet Inc 1.89777% Communication Services US £22,945,146.00 130,200
Raymond James Financial Inc 1.88236% Financials US £22,758,881.04 148,392
KLA Corp 1.69730% Information Technology US £20,521,403.40 22,910
BeOne Medicines Ltd 1.63862% Health Care US £19,811,977.08 81,844
Alibaba Group Holding Ltd 1.62087% Consumer Discretionary US £19,597,248.00 172,800

Prices and distribution

Prices

NAV Price (GBP)
£1,785.89
Change
+£12.750.72%
At closure 29 Oct 2025
NAV 52-week high
£1,773.14
At closure 29 Oct 2025
NAV 52-week low
£1,192.97
At closure 29 Oct 2025
NAV 52-week difference
£580.17
Change
+32.72%
At closure 29 Oct 2025
Historical Prices

-

Inception date

19 Dec 2006

Date NAV (GBP)
29 Oct 2025 £1,785.8875
28 Oct 2025 £1,773.1354
27 Oct 2025 £1,773.0770
24 Oct 2025 £1,764.9176
23 Oct 2025 £1,740.5590
22 Oct 2025 £1,712.3358
21 Oct 2025 £1,728.7035
20 Oct 2025 £1,736.3142
17 Oct 2025 £1,706.7592
16 Oct 2025 £1,705.2383

Distribution history

Distribution frequency

Annually

Historical performance 30 Sep 2025

0.61%

TypeDistribution amount (per unit)Ex-dividend dateRegistration datePayable date
Income £0.0000 31 Dec 2024 30 Dec 2024 15 Jan 2025
Income £0.0000 29 Dec 2023 28 Dec 2023 15 Jan 2024
Income £0.0000 30 Dec 2022 29 Dec 2022 16 Jan 2023
Income £0.0000 31 Dec 2021 30 Dec 2021 14 Jan 2022
Income £0.0000 31 Dec 2020 30 Dec 2020 14 Jan 2021
Income £0.0000 30 Dec 2010 23 Dec 2010 04 Jan 2011
Income £0.1140 31 Dec 2007 28 Dec 2007 04 Jan 2008

Purchase information

Currency

Base currency: GBP

Fund codes

  • Bloomberg: VANGUOG
  • Citi: HRG5
  • ISIN: IE00B1GHC616
  • MEX ID: VIUSOI
  • SEDOL: B1GHC61